Design of a transdermal formulation containing raloxifene nanoparticles for osteoporosis treatment

Noriaki Nagai,1 Fumihiko Ogata,1 Hiroko Otake,1 Yosuke Nakazawa,2 Naohito Kawasaki1 1Faculty of Pharmacy, Kindai University, Higashi-Osaka, Osaka, Japan; 2Faculty of Pharmacy, Keio University, Minato-ku, Tokyo, Japan Purpose: In the clinical setting, raloxifene, a second-generation selective estro...

Full description

Bibliographic Details
Main Authors: Nagai N, Ogata F, Otake H, Nakazawa Y, Kawasaki N
Format: Article
Language:English
Published: Dove Medical Press 2018-09-01
Series:International Journal of Nanomedicine
Subjects:
Online Access:https://www.dovepress.com/design-of-a-transdermal-formulation-containing-raloxifene-nanoparticle-peer-reviewed-article-IJN